secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0000950170-24-079653
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo raises ~$2.75M gross in registered direct offering at $0.515/share
-------------------------------------------------------------------------

- Offering of 5,339,806 shares (or pre-funded warrants) and 10,679,612 common warrants at $0.515/share; net proceeds ~$2.3M.
- Common warrants exercisable at $0.515/share upon stockholder approval, expire 5 years later.
- Existing warrants from Aug 2023, Nov 2023, Apr 2024 amended to $0.515 exercise price, also subject to stockholder approval.
- Proceeds for clinical development of product candidates and working capital.
- Roth Capital Partners placement agent; closing July 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024079653/0000950170-24-079653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024079653/apvo-20240628.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-079653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer